Jairath, Vipul
Gibble, Theresa Hunter
Moses, Richard
Klooster, Brittany
Litcher-Kelly, Leighann
Walker, Marisa http://orcid.org/0009-0004-2423-0043
Bernstein, Madison C
Rupinski, Kaelyn
McLafferty, Megan
Travis, Simon
Dubinsky, Marla
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
Article History
Received: 22 January 2024
Accepted: 16 May 2024
First Online: 31 May 2024
Declarations
:
: Ethics approval was received by a centralized independent review board, Sterling Independent Review Board (IRB; IRB ID #9213), prior to interview conduct. All patients provided written informed consent to participate, as well as verbal consent at the beginning of the interview to be audio-recorded.
: Not applicable; this manuscript [and/or its supplementary materials] do not contain any individual person’s data in any form (including any individual details, images, or videos).
: THG and RM are employees and stockholders of Eli Lilly and Company (US). MD, ST, and VJ are consultants previously and/or currently employed by Eli Lilly and Company (US). ST provided grants and/or research support to Eli Lilly and Company (US) and was also a speaker for Eli Lilly and Company (US). LLK, BK, MW, MCB and KR are employees of Adelphi Values; Adelphi Values received payment from Eli Lilly and Company (US) to conduct qualitative interviews, analysis, and report writing. MM was employed by Adelphi Values at the time this research was conducted.